BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics.

FFR-Guided Complete Revascularization Did Not Improve Outcomes in MI Patients

ATLANTA — Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in

April 11, 2024

Early feasibility studies on climate-friendly albuterol inhaler completed

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler

May 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics

Study sheds light on how cells repair damaged DNA

FFR-Guided Complete Revascularization Did Not Improve Outcomes in MI Patients

Early feasibility studies on climate-friendly albuterol inhaler completed

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe